Literature DB >> 14603576

Aging or osteoarthritis: which is the problem?

Richard F Loeser1, Najia Shakoor.   

Abstract

OA is not an inevitable consequence of aging, but aging-related changes in the musculoskeletal system increase the risk of developing OA if other risk factors are also present. The joint is a functioning biomechanical unit of the neuromuscular system. Factors that contribute to the development of joint pain and loss of joint function include those associated with aging, those associated with underuse or misuse of the musculoskeletal system, and those associated directly with the development of OA. Complex interactions exist among many of these factors such as strength, balance, and proprioception, which are affected by aging, underuse, and OA. Many older adults who have joint pain and loss of function do not exhibit structural changes of OA that can be detected by standard radiography. When structural damage is present, its contribution to pain and disability is not always clear. In the absence of pharmacologic agents that can prevent the progression of structural damage in OA, management of older adults who have joint pain and loss of function should focus on improving neuromuscular function and preventing further declines.

Entities:  

Mesh:

Year:  2003        PMID: 14603576     DOI: 10.1016/s0889-857x(03)00062-0

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  20 in total

Review 1.  Molecular mechanisms of cartilage destruction: mechanics, inflammatory mediators, and aging collide.

Authors:  Richard F Loeser
Journal:  Arthritis Rheum       Date:  2006-05

2.  [Histopathological examination of joint degeneration: typing, grading and staging of osteoarthritis].

Authors:  T Aigner; S Söder
Journal:  Pathologe       Date:  2006-11       Impact factor: 1.011

3.  A painful interface between normal aging and disease.

Authors:  Shari Miura Ling; Eleanor M Simonsick; Luigi Ferrucci
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2007-06       Impact factor: 6.053

Review 4.  [Osteoarthritis--histopathologic diagnosis: typing, grading, and staging].

Authors:  J Zustin; T Aigner
Journal:  Orthopade       Date:  2009-06       Impact factor: 1.087

5.  Epigenetically mediated spontaneous reduction of NFAT1 expression causes imbalanced metabolic activities of articular chondrocytes in aged mice.

Authors:  M Zhang; Q Lu; B Egan; X-B Zhong; K Brandt; J Wang
Journal:  Osteoarthritis Cartilage       Date:  2016-02-20       Impact factor: 6.576

Review 6.  Baboons as a model to study genetics and epigenetics of human disease.

Authors:  Laura A Cox; Anthony G Comuzzie; Lorena M Havill; Genesio M Karere; Kimberly D Spradling; Michael C Mahaney; Peter W Nathanielsz; Daniel P Nicolella; Robert E Shade; Saroja Voruganti; John L VandeBerg
Journal:  ILAR J       Date:  2013

7.  Increased matrix metalloproteinase-13 production with aging by human articular chondrocytes in response to catabolic stimuli.

Authors:  Christopher B Forsyth; Ada Cole; Gillian Murphy; Julia L Bienias; Hee-Jeong Im; Richard F Loeser
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2005-09       Impact factor: 6.053

8.  Reproductive status and sex show strong effects on knee OA in a baboon model.

Authors:  T E Macrini; H B Coan; S M Levine; T Lerma; C D Saks; D J Araujo; T L Bredbenner; R D Coutts; D P Nicolella; L M Havill
Journal:  Osteoarthritis Cartilage       Date:  2013-03-14       Impact factor: 6.576

Review 9.  [Typing, grading and staging of osteoarthritis: histopathological assessment of joint degeneration].

Authors:  T Aigner; S Söder
Journal:  Z Rheumatol       Date:  2008-02       Impact factor: 1.372

10.  Endogenous production of reactive oxygen species is required for stimulation of human articular chondrocyte matrix metalloproteinase production by fibronectin fragments.

Authors:  Marcello Del Carlo; Daniel Schwartz; Elizabeth A Erickson; Richard F Loeser
Journal:  Free Radic Biol Med       Date:  2007-01-24       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.